We do not dare invest in the stock market at a time when almost all the stocks, both large and small, are yo-yoing for unknown reasons. The positive criteria has all but vanished, leaving behind it unparalleled inflation that is causing enormous chaos.
Karyopharm Therapeutics Inc
During this hectic atmosphere Karyopharm Therapeutics (KPTI) announced that its Phase 3 SIENDO study has met . . .
This content is for paid subscribers.
Impacting News February 14, 2022